• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测心房颤动合并阻塞性慢性冠状动脉综合征患者的死亡率:比亚韦斯托克冠状动脉项目

Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project.

作者信息

Kuźma Łukasz, Tomaszuk-Kazberuk Anna, Kurasz Anna, Dobrzycki Sławomir, Koziński Marek, Sobkowicz Bożena, Lip Gregory Y H

机构信息

Department of Invasive Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.

Department of Cardiology, Medical University of Białystok, 15-089 Białystok, Poland.

出版信息

J Clin Med. 2021 Oct 26;10(21):4949. doi: 10.3390/jcm10214949.

DOI:10.3390/jcm10214949
PMID:34768472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8584483/
Abstract

Over the next decades, the prevalence of atrial fibrillation (AF) is estimated to double. Our aim was to investigate the causes of the long-term mortality in relation to the diagnosis of atrial fibrillation (AF) and chronic coronary syndrome (CCS). The analysed population consisted of 7367 consecutive patients referred for elective coronary angiography enrolled in a large single-centre retrospective registry, out of whom 1484 had AF and 2881 were diagnosed with obstructive CCS. During follow-up (median = 2029 days), 1201 patients died. The highest all-cause death was seen in AF(+)/CCS(+) [194/527; 36.8%], followed by AF(+)/CCS(-) [210/957; 21.9%], AF(-)/CCS(+) [(459/2354; 19.5%)] subgroups. AF ([HR] = 1.48, 95%CI, 1.09-2.01; HR = 1.34, 95%CI, 1.07-1.68) and obstructive CCS (HR = 1.90, 95%CI, 1.56-2.31; HR = 2.27, 95%CI, 1.94-2.65) together with age, male gender, heart failure, obstructive pulmonary disease, diabetes were predictors of both all-cause and CV mortality. The main findings are as follow among patients referred for elective coronary angiography, both AF and obstructive CCS are strong and independent predictors of the long-term mortality. Mortality of AF without CCS was at least as high as non-AF patients with CCS. CV deaths were more frequent than non-CV deaths in AF patients with CCS compared to those with either AF or CCS alone.

摘要

在接下来的几十年里,房颤(AF)的患病率预计将翻倍。我们的目的是调查与房颤(AF)和慢性冠状动脉综合征(CCS)诊断相关的长期死亡率原因。分析的人群包括7367例连续接受择期冠状动脉造影的患者,这些患者被纳入一个大型单中心回顾性登记研究,其中1484例患有房颤,2881例被诊断为阻塞性CCS。在随访期间(中位数 = 2029天),1201例患者死亡。全因死亡率最高的是AF(+)/CCS(+)组[194/527;36.8%],其次是AF(+)/CCS(-)组[210/957;21.9%]、AF(-)/CCS(+)组[(459/2354;19.5%)]。房颤([HR]=1.48,95%CI,1.09 - 2.01;HR = 1.34,95%CI,1.07 - 1.68)和阻塞性CCS(HR = 1.90,95%CI,1.56 - 2.31;HR = 2.27,95%CI,1.94 - 2.65)以及年龄、男性性别、心力衰竭、阻塞性肺病、糖尿病是全因死亡率和心血管死亡率的预测因素。在接受择期冠状动脉造影的患者中,主要发现如下:房颤和阻塞性CCS都是长期死亡率的强有力独立预测因素。无CCS的房颤患者死亡率至少与有CCS的非房颤患者一样高。与单独患有房颤或CCS的患者相比,患有CCS的房颤患者心血管死亡比非心血管死亡更频繁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/4cdb22dabd3c/jcm-10-04949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/52eccfce21c5/jcm-10-04949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/ae7319a382c1/jcm-10-04949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/32bf44443e7a/jcm-10-04949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/4cdb22dabd3c/jcm-10-04949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/52eccfce21c5/jcm-10-04949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/ae7319a382c1/jcm-10-04949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/32bf44443e7a/jcm-10-04949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5091/8584483/4cdb22dabd3c/jcm-10-04949-g004.jpg

相似文献

1
Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project.预测心房颤动合并阻塞性慢性冠状动脉综合征患者的死亡率:比亚韦斯托克冠状动脉项目
J Clin Med. 2021 Oct 26;10(21):4949. doi: 10.3390/jcm10214949.
2
Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project.心房颤动与非阻塞性冠状动脉病变的相关性更高:比亚韦斯托克冠状动脉项目。
Pol Arch Intern Med. 2020 Dec 22;130(12):1029-1036. doi: 10.20452/pamw.15635. Epub 2020 Oct 5.
3
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.慢性阻塞性肺疾病对心房颤动预后的影响:欧洲观察性研究计划心房颤动试点调查(EORP-AF)总登记处的报告
Am Heart J. 2016 Nov;181:83-91. doi: 10.1016/j.ahj.2016.08.011. Epub 2016 Aug 27.
4
A Newly Defined CHADS-VA Score for Predicting Obstructive Coronary Artery Disease in Patients with Atrial Fibrillation-A Cross-Sectional Study of Older Persons Referred for Elective Coronary Angiography.一种新定义的CHADS-VA评分用于预测心房颤动患者的阻塞性冠状动脉疾病——一项针对接受择期冠状动脉造影的老年人的横断面研究。
J Clin Med. 2022 Jun 16;11(12):3462. doi: 10.3390/jcm11123462.
5
Impact of coronary artery disease and revascularization on recurrence of atrial fibrillation after catheter ablation: Importance of ischemia in managing atrial fibrillation.冠心病及血运重建对导管消融术后心房颤动复发的影响:缺血在心房颤动管理中的重要性。
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1491-1498. doi: 10.1111/jce.14029. Epub 2019 Jun 25.
6
Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study.心房颤动患者住院的发生率和预测因素:来自中国心房颤动注册研究的结果。
BMC Cardiovasc Disord. 2021 Mar 19;21(1):146. doi: 10.1186/s12872-021-01951-5.
7
Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography.冠状动脉计算机断层扫描血管造影术识别的房颤患者亚临床冠状动脉疾病的预测价值。
Am J Cardiol. 2020 Jul 1;126:16-22. doi: 10.1016/j.amjcard.2020.03.050. Epub 2020 Apr 7.
8
Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).欧洲心脏病专家对心房颤动患者的预后和治疗:EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase(EORP-AF Pilot 注册研究)的一年随访结果。
Eur Heart J. 2014 Dec 14;35(47):3365-76. doi: 10.1093/eurheartj/ehu374. Epub 2014 Aug 31.
9
Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlap.冠心病、心房颤动或心力衰竭门诊患者的二级预防及结局:关注疾病重叠情况
Open Heart. 2020 Apr 21;7(1):e001165. doi: 10.1136/openhrt-2019-001165. eCollection 2020.
10
Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome.新发心房颤动与已知心房颤动及无心房颤动对急性冠状动脉综合征患者 30 天和 10 年死亡率的影响。
Am J Cardiol. 2012 Jul 15;110(2):217-21. doi: 10.1016/j.amjcard.2012.03.018. Epub 2012 Apr 20.

引用本文的文献

1
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024.易与否。欧亚六国关于近期指南的年度共识:动脉高血压、心房颤动、慢性冠状动脉综合征和外周动脉疾病。这些患者的新型或传统治疗选择。2024年立场文件
Cardiol J. 2025;32(3):213-227. doi: 10.5603/cj.105140. Epub 2025 May 13.
2
Comparing Atrial-Fibrillation Validated Rapid Scoring Systems in the Long-Term Mortality Prediction in Patients Referred for Elective Coronary Angiography: A Subanalysis of the Białystok Coronary Project.比较在择期冠状动脉造影患者中长期死亡率预测中经过验证的心房颤动快速评分系统:比亚韦斯托克冠状动脉项目的一项亚分析。
Int J Environ Res Public Health. 2022 Aug 21;19(16):10419. doi: 10.3390/ijerph191610419.

本文引用的文献

1
Atrial Fibrillation and Chronic Kidney Disease-A Risky Combination for Post-Contrast Acute Kidney Injury.心房颤动与慢性肾脏病——造影剂后急性肾损伤的危险组合。
J Clin Med. 2021 Sep 14;10(18):4140. doi: 10.3390/jcm10184140.
2
Comorbidities Associated with One-Year Mortality in Patients with Atrial Fibrillation and Heart Failure.心房颤动合并心力衰竭患者一年死亡率的相关共病
Healthcare (Basel). 2021 Jul 1;9(7):830. doi: 10.3390/healthcare9070830.
3
Prevalence of atrial fibrillation dependent on coronary artery status: Insights from the LIFE-Heart Study.
房颤的患病率与冠状动脉状况有关:来自 LIFE-Heart 研究的见解。
Clin Cardiol. 2020 Dec;43(12):1616-1623. doi: 10.1002/clc.23490. Epub 2020 Oct 27.
4
Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project.心房颤动与非阻塞性冠状动脉病变的相关性更高:比亚韦斯托克冠状动脉项目。
Pol Arch Intern Med. 2020 Dec 22;130(12):1029-1036. doi: 10.20452/pamw.15635. Epub 2020 Oct 5.
5
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
6
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.21 世纪心房颤动的流行病学:新方法与新见解。
Circ Res. 2020 Jun 19;127(1):4-20. doi: 10.1161/CIRCRESAHA.120.316340. Epub 2020 Jun 18.
7
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新:来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
8
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
9
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
10
Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study.心房颤动患者的死亡率和死因:一项全国范围内基于人群的研究。
PLoS One. 2018 Dec 26;13(12):e0209687. doi: 10.1371/journal.pone.0209687. eCollection 2018.